Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group

Published:2016-07-04 Issue:9 Volume:139 Page:1930-1935
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Sung Lillian¹,Aplenc Richard²,Alonzo Todd A.³⁴,Gerbing Robert B.³,Wang Yi-Cheng³,Meshinchi Soheil⁵,Gamis Alan S.⁶

Affiliation:

1. The Division of Haematology/Oncology; The Hospital for Sick Children; Toronto ON Canada

2. Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia; PA USA

3. Children's Oncology Group; Monrovia CA USA

4. Department of Biostatistics, University of Southern California; Los Angeles CA USA

5. Division of Oncology, Fred Hutchinson Cancer Research Center; Seattle WA USA

6. Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics; Kansas City MO USA

Funder

Chair's Grant, Children's Oncology Group from the National Cancer Institute;

National Institutes of Health, Bethesda, MD, USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93;Lehrnbecher;Leukemia,2004

2. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia;Sung;Blood,2007

3. Pharmacogenomics in acute myeloid leukemia;Roumier;Pharmacogenomics,2009

4. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase iII children's oncology group Trial AAML0531;Gamis;J Clin Oncol,2014

5. Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial;Gibson;Br J Haematol,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms;Frontiers in Immunology;2024-02-15

2. Leukemic transformation during anti-tuberculosis treatment in aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report and review of literature;World Journal of Clinical Cases;2023-10-06

3. Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma;Cancer Research and Treatment;2022-01-15

4. Neutropenia in the First Cycle of Consolidation Chemotherapy with High-Dose Cytarabine Is Not Associated with the Incidence of Relapse in Adult Acute Myeloid Leukemia Patients in First Complete Remission;Acta Haematologica;2022

5. Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study;British Journal of Haematology;2020-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3